XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Wall St rises ahead of key Fed decision; S&P 500 nears record high



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall St rises ahead of key Fed decision; S&P 500 nears record high</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Microsoft gains after new share buyback plan, dividend hike

Intel jumps following collaboration with Amazon's AWS

Retail sales unexpectedly rise 0.10% in August

Indexes up: Dow 0.19%, S&P 500 0.38%, Nasdaq 0.72%

Updated at 09:49 a.m. ET/1349 GMT

By Johann M Cherian and Purvi Agarwal

Sept 17 (Reuters) -Wall Street's main indexes rose on Tuesday, with the benchmark S&P 500 close to its intraday record high, as investors awaited a crucial Federal Reserve policy decision and fresh economic dataallayed worries of a sharp slowdown in the U.S. economy.

A Commerce Department reportshowed retail sales roseunexpectedly in August, as a decline in receipts at auto dealerships was offset by strength in online purchases, suggesting the economy was onsolid footing through much of the third quarter.

Rate-sensitive growth stocks such as Alphabet GOOGL.O and Tesla <TSLA.O> added 1.0%and 1.90%,while Nvidia NVDA.O edged up 0.44%, pushing the broader chips index .SOX higher 0.60%.

Microsoft MSFT.O boosted the S&P 500with a 2.3% rise on the day after the AI-frontrunner's board approved a new $60-billion share buyback program and hiked its quarterly dividend by 10%. The broader tech sector .SPLRCT climbed 0.70%.

At 09:49 a.m. ET, the Dow Jones Industrial Average .DJI rose 78.70 points, or 0.19%, to 41,706.55, the S&P 500 .SPX gained 21.50 points, or 0.38%, to 5,654.59 and the Nasdaq Composite .IXIC gained 126.91 points, or 0.72%, to 17,719.03.

The blue-chip Dow traded at a record high and the Russell 2000 index .RUT tracking small caps - which tend to perform better in a low-interest-rate environment - advanced 0.71%.

Seven of the 11 S&P 500 sectors traded higher, led by a 1% rise in Consumer Discretionary .SPLRCD stocks.

With Fedofficials scheduled to commence their two-day meeting, traders are betting on a 65% probability theworld's most influential central bank will decide to lower borrowing costs by a bigger 50 basis points, according to the CME Group's FedWatch Tool.

Odds favoring a smaller 25-bps reduction stand at 35% from 66% a week earlier, as investors focused on remarks from a former policymaker supporting an outsized move and signs of a cooling labor market, among other indicators.

"Retail sales being higher is suggestive that the economy is modestly better," said Michael Green, chief strategist and portfolio manager at Simplify Asset Management.

"I would say that the actual underlying data is relatively mixed and markets are in a bit of a holding pattern, waiting for (Chair Jerome) Powell and the Federal Reserve tomorrow."

September has historically been weak for U.S. equities, with the benchmark S&P 500 down about 1.20% for the month on an average since 1928. However, factoring in theday's gains, the index is up about 0.20% so far this September.

Still, a survey of BofA fund managers showed global investor sentiment improved in September 2024 for the first time since June on optimism around a soft landing and rate cuts by the U.S. central bank.

Among other movers, Intel INTC.O rose 2.3% after signing Amazon.com's AMZN.O cloud services unit as a customer to make custom artificial-intelligence chips. Amazon.com AMZN.O gained 2%.

Viasat VSAT.O dropped 6.1% after brokerage J.P.Morgan downgraded it to "neutral" from "overweight".

Advancing issues outnumbered decliners by a 2.93-to-1 ratio on the NYSE, and by a 2.32-to-1 ratio on the Nasdaq.

The S&P 500 posted 30 new 52-week highs and no new lows, while the Nasdaq Composite recorded 62 new highs and 27 new lows.



Reporting by Johann M Cherian in Bengaluru; Editing by Pooja Desai

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.